国际干细胞研究学会干细胞研究和临床转化指南：支持安全有效的基于干细胞的干预措施的发展。
ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions.
机构信息
University of Minnesota Center for Bioethics, School of Public Health, and College of Pharmacy, Minneapolis, MN 55455, USA.
出版信息
Stem Cell Reports. 2021 Jun 8;16(6):1394-1397. doi: 10.1016/j.stemcr.2021.05.011. Epub 2021 May 27.
Abstract
The ISSCR's revised Guidelines for Stem Cell Research and Clinical Translation reflect the organization's commitment to opposing premature commercialization of stem cell-based interventions and supporting the development of products that meet stringent ethical, scientific, and regulatory standards. The Guidelines contain five important new recommendations concerning clinical translation of stem cell products.
摘要
ISSCR 修订后的干细胞研究和临床转化指南反映了该组织反对过早将基于干细胞的干预措施商业化的承诺，并支持开发符合严格的伦理、科学和监管标准的产品。这些指南包含了关于干细胞产品临床转化的五条重要的新建议。
相似文献
1
ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions.国际干细胞研究学会干细胞研究和临床转化指南：支持安全有效的基于干细胞的干预措施的发展。
Stem Cell Reports. 2021 Jun 8;16(6):1394-1397. doi: 10.1016/j.stemcr.2021.05.011. Epub 2021 May 27.
2
Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines.制定全球干细胞研究和临床转化标准：2016 年 ISSCR 指南。
Stem Cell Reports. 2016 Jun 14;6(6):787-797. doi: 10.1016/j.stemcr.2016.05.001. Epub 2016 May 12.
3
Guidelines for stem cell science and clinical translation.干细胞科学与临床转化指南。
Indian J Med Ethics. 2016 Jul-Sep;1(3):160-1. doi: 10.20529/IJME.2016.044. Epub 2016 Jun 6.
4
ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update.国际干细胞研究学会干细胞研究与临床转化指南：2021 年更新版。
Stem Cell Reports. 2021 Jun 8;16(6):1398-1408. doi: 10.1016/j.stemcr.2021.05.012. Epub 2021 May 27.
5
Human embryo research, stem cell-derived embryo models and in vitro gametogenesis: Considerations leading to the revised ISSCR guidelines.人类胚胎研究、干细胞衍生胚胎模型和体外配子发生：导致 ISSCR 指南修订的考虑因素。
Stem Cell Reports. 2021 Jun 8;16(6):1416-1424. doi: 10.1016/j.stemcr.2021.05.008. Epub 2021 May 27.
6
ISSCR guidelines for the transfer of human pluripotent stem cells and their direct derivatives into animal hosts.ISCR 人类多能干细胞及其直接衍生细胞向动物宿主转移的指导原则。
Stem Cell Reports. 2021 Jun 8;16(6):1409-1415. doi: 10.1016/j.stemcr.2021.05.005. Epub 2021 May 27.
7
Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report.解决基于干细胞疗法过早分娩的伦理挑战：ISSCR 2018 年年会重点会议报告。
Stem Cell Reports. 2018 Nov 13;11(5):1021-1025. doi: 10.1016/j.stemcr.2018.10.020.
8
Cédric Blanpain: ISSCR's outstanding young investigator for 2012.塞德里克·布兰潘：2012 年 ISSCR 杰出青年研究员。
Cell Stem Cell. 2012 Jun 14;10(6):751-752. doi: 10.1016/j.stem.2012.05.001.
9
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modeling.国际干细胞研究学会（ISSCR）指南在疾病建模中的作用。
Dis Model Mech. 2024 Jul 1;17(7). doi: 10.1242/dmm.050947. Epub 2024 Jul 8.
10
Profile: George Daley, ISSCR's president elect.简介：乔治·戴利，国际干细胞研究学会候任主席。
Cell Stem Cell. 2007 Jun 7;1(1):21-2. doi: 10.1016/j.stem.2007.05.005.
引用本文的文献
1
Stem Cell-Derived Exosomes: A Comprehensive Review of Biomedical Applications, Challenges, and Future Directions.干细胞衍生外泌体：生物医学应用、挑战及未来方向的全面综述
Int J Nanomedicine. 2025 Sep 4;20:10857-10905. doi: 10.2147/IJN.S527137. eCollection 2025.
2
Stem Cell for Cancer Immunotherapy: Current Approaches and Challenges.用于癌症免疫治疗的干细胞：当前方法与挑战
Stem Cell Rev Rep. 2025 Oct;21(7):1931-1954. doi: 10.1007/s12015-025-10933-5. Epub 2025 Jul 12.
3
Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases.将线粒体生物学融入神经退行性疾病的创新细胞疗法
Brain Sci. 2024 Sep 5;14(9):899. doi: 10.3390/brainsci14090899.
4
Standardisation is the key to the sustained, rapid and healthy development of stem cell-based therapy.标准化是干细胞治疗持续、快速和健康发展的关键。
Clin Transl Med. 2024 Apr;14(4):e1646. doi: 10.1002/ctm2.1646.
5
The impact of induced pluripotent stem cells in animal conservation.诱导多能干细胞对动物保护的影响。
Vet Res Commun. 2024 Apr;48(2):649-663. doi: 10.1007/s11259-024-10294-3. Epub 2024 Jan 16.
6
Effect of miR-21 in mesenchymal stem cells-derived extracellular vesicles behavior.miR-21 对间充质干细胞衍生细胞外囊泡行为的影响。
Stem Cell Res Ther. 2023 Dec 21;14(1):383. doi: 10.1186/s13287-023-03613-z.
7
KAP1 phosphorylation promotes the survival of neural stem cells after ischemia/reperfusion by maintaining the stability of PCNA.KAP1 磷酸化通过维持 PCNA 的稳定性促进缺血/再灌注后神经干细胞的存活。
Stem Cell Res Ther. 2022 Jul 7;13(1):290. doi: 10.1186/s13287-022-02962-5.
本文引用的文献
1
Complications from "Stem Cell Tourism" in Neurology.神经科中的“干细胞旅游”带来的并发症。
Ann Neurol. 2020 Oct;88(4):661-668. doi: 10.1002/ana.25842. Epub 2020 Jul 29.
2
The Magic of Randomization versus the Myth of Real-World Evidence.随机化的魔力与真实世界证据的神话
N Engl J Med. 2020 Feb 13;382(7):674-678. doi: 10.1056/NEJMsb1901642.
3
Downgrading of regulation in regenerative medicine.再生医学监管的降级
Science. 2019 Aug 16;365(6454):644-646. doi: 10.1126/science.aax6184.
4
Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report.解决基于干细胞疗法过早分娩的伦理挑战：ISSCR 2018 年年会重点会议报告。
Stem Cell Reports. 2018 Nov 13;11(5):1021-1025. doi: 10.1016/j.stemcr.2018.10.020.
5
Co-opting of ClinicalTrials.gov by patient-funded studies.患者资助研究对ClinicalTrials.gov的占用。
Lancet Respir Med. 2018 Aug;6(8):579-581. doi: 10.1016/S2213-2600(18)30242-X. Epub 2018 Jun 19.
6
Balancing Safety and Innovation for Cell-Based Regenerative Medicine.平衡基于细胞的再生医学的安全性与创新性。
N Engl J Med. 2018 Mar 8;378(10):954-959. doi: 10.1056/NEJMsr1715626.
7
The malignant niche: safe spaces for toxic stem cell marketing.恶性微环境：有毒干细胞营销的安全空间。
NPJ Regen Med. 2017 Dec 19;2:33. doi: 10.1038/s41536-017-0036-x. eCollection 2017.
8
Clarifying Stem-Cell Therapy's Benefits and Risks.阐明干细胞疗法的益处与风险。
N Engl J Med. 2017 Mar 16;376(11):1007-1009. doi: 10.1056/NEJMp1613723. Epub 2016 Nov 30.
9
Global Distribution of Businesses Marketing Stem Cell-Based Interventions.全球营销基于干细胞的干预措施的企业分布。
Cell Stem Cell. 2016 Aug 4;19(2):158-162. doi: 10.1016/j.stem.2016.07.015.
10
Glioproliferative Lesion of the Spinal Cord as a Complication of "Stem-Cell Tourism".脊髓胶质增生性病变作为“干细胞旅游”的并发症
N Engl J Med. 2016 Jul 14;375(2):196-8. doi: 10.1056/NEJMc1600188. Epub 2016 Jun 22.
Zotero 插件